Morgan Stanley lowered the firm’s price target on Docebo (DCBO) to $26 from $28 and keeps an Equal Weight rating on the shares. On the positive side, the firm learned this was one of Docebo’s strongest gross bookings quarters since 2021, however it still views Docebo as a “show-me story,” the analyst tells investors following earnings.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DCBO:
- Docebo price target lowered to $28 from $34 at Stifel
- Midday Fly By: Paramount wins Warner bidding, Amazon to invest $5oB in OpenAI
- Morning Movers: Block pops after over 40% headcount reduction
- Docebo Posts Strong Q4 2025 Results and Pushes Ahead With $60 Million Share Buyback
- Docebo reports Q4 adjusted EPS 46c, consensus 36c